Generic Pharmaceuticals Company Equity Stake For Sale in Muscat, Oman
UK-registered healthcare company with growing Oman sales, branded products, and GCC expansion opportunities, seeking investment.
Premium Plan
| Established | 1-5 year(s) |
| Employees | 10 - 50 |
| Legal Entity | Limited Liability Company (LLC) |
| Reported Sales | USD 600 - 700 thousand |
| Run Rate Sales | USD 940 thousand |
| EBITDA Margin | 20 - 30 % |
| Industries | Generic Pharmaceuticals |
| Locations | Muscat |
| Local Time | 8:59 PM Asia / Muscat |
| Listed By | Business Owner / Director |
| Status | Active |
Partial Stake Sale
USD
1.3 million
for
30.0%
stake
(Native Currency: OMR 500,000)
Reason: We are seeking investment primarily to accelerate the next phase of growth and geographic expansion,...
View More
Includes physical assets worth
USD
52 thousand
Interested in connecting with advisors
Name, Phone, Email
Available after connect
Business Name
Not disclosed
User Verification
Business Overview
- UK-registered pharmaceutical and healthcare company focused on the development, registration, marketing, and commercialization of pharmaceutical, nutraceutical, and dietary supplement products.
- The company has an established commercial presence in Oman and follows an asset-light model, working with qualified European and international contract manufacturers while retaining control over its brands, product portfolio, regulatory strategy, and commercialization.
- Products are marketed through 2 authorized distribution partners in Oman, who supply pharmacies, clinics, hospitals, and healthcare retail outlets.
- Annual sales have grown from approximately OMR 13,000 at inception to OMR 247,744 in the last reported year, demonstrating strong commercial growth.
- The portfolio covers vitamins, minerals, nutritional supplements, and specialized healthcare categories including immunity, women's health, bone health, iron supplementation, neurological support, digestive health, sleep support, electrolytes, and general wellness.
- The company has invested in proprietary product concepts and formulations, trademarks, regulatory dossiers, packaging and artwork, technical documentation, and brand development.
- The management team has hands-on experience across pharmaceutical product development, international sourcing, regulatory affairs, contract manufacturing, distribution, sales and marketing, and GCC market development.
- The company has developed relationships with pharmaceutical and nutraceutical manufacturers, laboratories, raw-material suppliers, regulatory service providers, distributors, pharmacies, and other commercial partners across the UK, Europe, Oman, and other international markets.
- The business has practical experience in product registration and regulatory compliance, including technical dossiers, specifications, quality-control documentation, methods of analysis, reference standards, product artwork, and post-submission requirements.
- The next phase of growth is focused on expanding into Saudi Arabia, UAE, Qatar, Kuwait, and Bahrain, alongside continued product portfolio expansion and development of additional manufacturing partnerships.
- The company operates without significant manufacturing infrastructure investment by using contract manufacturing partners selected according to dosage form, technical capability, quality standards, capacity, and commercial requirements.
- Contract employees are hired as needed to ensure smooth operations.
- The business holds a Trade License, Marketing Authorization License, and trademarked brand, supporting its existing commercialization and brand ownership.
- Its key strengths include commercial growth, an expanding product portfolio, regulatory capabilities, established distributor relationships, and experience in the GCC healthcare market.
- The company has an established commercial presence in Oman and follows an asset-light model, working with qualified European and international contract manufacturers while retaining control over its brands, product portfolio, regulatory strategy, and commercialization.
- Products are marketed through 2 authorized distribution partners in Oman, who supply pharmacies, clinics, hospitals, and healthcare retail outlets.
- Annual sales have grown from approximately OMR 13,000 at inception to OMR 247,744 in the last reported year, demonstrating strong commercial growth.
- The portfolio covers vitamins, minerals, nutritional supplements, and specialized healthcare categories including immunity, women's health, bone health, iron supplementation, neurological support, digestive health, sleep support, electrolytes, and general wellness.
- The company has invested in proprietary product concepts and formulations, trademarks, regulatory dossiers, packaging and artwork, technical documentation, and brand development.
- The management team has hands-on experience across pharmaceutical product development, international sourcing, regulatory affairs, contract manufacturing, distribution, sales and marketing, and GCC market development.
- The company has developed relationships with pharmaceutical and nutraceutical manufacturers, laboratories, raw-material suppliers, regulatory service providers, distributors, pharmacies, and other commercial partners across the UK, Europe, Oman, and other international markets.
- The business has practical experience in product registration and regulatory compliance, including technical dossiers, specifications, quality-control documentation, methods of analysis, reference standards, product artwork, and post-submission requirements.
- The next phase of growth is focused on expanding into Saudi Arabia, UAE, Qatar, Kuwait, and Bahrain, alongside continued product portfolio expansion and development of additional manufacturing partnerships.
- The company operates without significant manufacturing infrastructure investment by using contract manufacturing partners selected according to dosage form, technical capability, quality standards, capacity, and commercial requirements.
- Contract employees are hired as needed to ensure smooth operations.
- The business holds a Trade License, Marketing Authorization License, and trademarked brand, supporting its existing commercialization and brand ownership.
- Its key strengths include commercial growth, an expanding product portfolio, regulatory capabilities, established distributor relationships, and experience in the GCC healthcare market.
Products & Services Overview
Branded pharmaceutical, nutraceutical, vitamin, mineral, and dietary supplement products supplied through authorized distributors to pharmacies, clinics, hospitals, and healthcare retail networks in Oman.
Assets Overview
Tangible assets:- Office furniture, fixtures and equipment.
- Computers, laptops, printers, mobile devices and other IT equipment.
- Product inventory/finished pharmaceutical and nutraceutical products owned by the company.
- Product samples, promotional samples and demonstration stock.
- Promotional and marketing materials, including brochures, displays and other branded materials.
Reference standards, laboratory/QC materials and retained/product samples owned by the company.
- Packaging materials, labels, cartons and printed materials, where purchased/owned by the company.
Intangible assets;
- Brand name and associated goodwill.
- Registered and pending trademarks, including product/brand trademarks.
- Product names, logos, artwork, packaging designs and brand identity.
- Proprietary product formulations, compositions and product specifications.
- Product development know-how and technical documentation.
- Regulatory dossiers and product registration documentation developed/owned by the company.
- Marketing authorisations/product registrations held in the company's name, where legally transferable/recognisable as an asset.
- Manufacturing know-how, specifications, methods of analysis, stability data and other technical documentation owned by the company.
- Commercial rights arising from manufacturing, supply, distribution, confidentiality and other contractual arrangements.
- Exclusive distribution/territorial rights, where applicable.
- Customer and distributor relationships and associated commercial goodwill.
- Customer, pharmacy, distributor, healthcare-professional and business-contact databases, subject to applicable data-protection laws.
- Supplier and contract-manufacturer network and associated commercial relationships.
- Pricing structures, commercial terms, sales strategies and market-entry plans.
- Sales history, market data and internally developed business intelligence.
- Website/domain names, company email domains and digital assets.
- Social-media accounts and digital marketing content.
- Copyright in company-created brochures, artwork, product literature, training materials and other original content.
- Confidential business information, trade secrets and proprietary commercial know-how.
- Standard operating procedures, internal policies, quality documentation and business processes developed by the company.
- Goodwill associated with the company's established presence, product portfolio, regulatory history and distribution network.
Facilities Overview
The current office has a built‑up area of 400 sqm and is a rented property.We are also exploring a central warehouse in the Airport Free Zone area.
Capitalization Overview
The business is self‑funded with contributions from friends and family. It has a total of two shareholders.
Tags:
Generic Pharmaceuticals Company Investment Opportunity in Muscat, Oman
·Generic Pharmaceuticals Company Equity Stake For Sale in Muscat, Oman
·Invest in Generic Pharmaceuticals Company in Muscat, Oman
·Generic Pharmaceuticals Company Investment Opportunity
·Invest in Generic Pharmaceuticals Company
·Investment Opportunity in Muscat, Oman
·Invest in Muscat, Oman
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
2 Investors viewed this Business this week.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 72,000+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses